West Broadway Family Dental, Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 385 West Broadway, South Boston, MA 02127 Phone: 617-268-8242 |
Sameka Dental Management Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 500 E Broadway, South Boston, MA 02127 Phone: 617-268-2333 Fax: 617-268-8894 |
Gentle Dental South Boston Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 368a W Broadway # A, South Boston, MA 02127 Phone: 617-269-0004 |
South Boston Dental Associates Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 29 Farragut Rd, South Boston, MA 02127 Phone: 617-268-1030 |
Norbert J Shay Dmd Pc Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 599 E Broadway, South Boston, MA 02127 Phone: 617-269-3957 |
Michael F. Arcieri, D.m.d., Inc. Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 590 E Broadway, South Boston, MA 02127 Phone: 617-268-1015 Fax: 617-268-1015 |
South Boston Family Dental Llc Dentist Medicare: Not Enrolled in Medicare Practice Location: 591 E Broadway, South Boston, MA 02127 Phone: 617-268-5638 |
News Archive
Dr Florent Ginhoux, Principal Investigator at the Singapore Immunology Network, has been awarded the prestigious EMBO Young Investigator 2013 award. The European Molecular Biology Organization Young Investigator Programme recognises young, promising researchers who are less than forty years of age and who have established their first laboratories in Europe and EMBO cooperation partner countries in the past four years.
A Mayo Clinic study of people who received anesthesia for surgery after age 40 found no association between the anesthesia and development of mild cognitive impairment later in life. Mild cognitive impairment is a stage between the normal cognitive decline of aging and dementia.
Chronic bronchitis is common among patients with chronic obstructive disease and may represent a subtype of the disease that places patients at risk for increased severity and exacerbations, say researchers.
Sanofi and the Global Alliance for TB Drug Development announced today a new research collaboration agreement to accelerate the discovery and development of novel compounds against tuberculosis (TB), a deadly infectious disease that resulted in almost 1.5 million deaths worldwide in 2010.
Antibiotics used to treat a variety of common bacterial infections are becoming more difficult to access, mostly because the drugs are less profitable for manufacturers to produce and market, say experts.
› Verified 7 days ago